CCMH
ECYT

Cornerstone Capital Management Holdings’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-11,800
Closed -$61K – 1572
2015
Q2 		$61K Sell
11,800
-7,900
-40% -$47.4K ﹤0.01% 1338
2015
Q1 		$123K Buy
19,700
+7,900
+67% +$45.6K ﹤0.01% 1244
2014
Q4 		$74K Sell
11,800
-4,300
-27% -$26.2K ﹤0.01% 1190
2014
Q3 		$98K Buy
+16,100
New +$110K ﹤0.01% 1176

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management Holdings's ECYT Position: Q3 2015 in Review

Cornerstone Capital Management Holdings sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2015, closing a stake of 11,800 shares — an estimated $61K sold.

Cornerstone Capital Management Holdings first reported a position in ECYT in Q3 2014 and held it in 4 quarters. The position peaked at $123K in Q1 2015. 104 funds tracked by Wall St. Rank hold ECYT as of Q3 2015.

  • Cornerstone Capital Management Holdings reported no remaining Endocyte, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 11,800 Endocyte, Inc. Common Stock shares in Q3 2015, an estimated $61K.
  • Cornerstone Capital Management Holdings first reported a position in Endocyte, Inc. Common Stock in Q3 2014 and held it in 4 quarters.
  • Cornerstone Capital Management Holdings's Endocyte, Inc. Common Stock position peaked at $123K in Q1 2015.
  • 104 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2015.

Based on Cornerstone Capital Management Holdings's 13F filing for Q3 2015, filed 12 Nov 2015.